Functional Gene Module-Based Identification of Phillyrin as an Anticardiac Fibrosis Agent

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Pharmacology

Background:

• Cardiac fibrosis (CF) significantly impacts heart disease treatment outcomes.
• Effective methods for identifying anti-CF drugs are limited.
• Developing novel therapeutic strategies for CF is a clinical priority.

Purpose of the Study:

• To construct a gene functional module representing the core pathology of CF.
• To screen for antifibrotic agents targeting this module.
• To validate the efficacy of potential agents in preclinical models.

Main Methods:

• Selected CF marker genes (Postn, Ddr2, Pdgfra) to build a genome-wide coexpression network module.
• Assessed module correlation with CF in human heart disease gene expression profiles.
• Utilized enrichment analysis to predict antifibrotic effects of phillyrin.
• Validated phillyrin's effects in a myocardial infarction animal model.

Main Results:

• A CF-related gene functional module was successfully constructed.
• The module showed significant correlation with cardiac fibrosis progression.
• Phillyrin was identified as a potential antifibrotic agent.
• Experimental validation confirmed phillyrin's cardioprotective and anti-CF effects.

Conclusions:

• Phillyrin is a promising novel antifibrotic agent for treating heart diseases.
• The gene functional module approach is effective for identifying anti-CF drugs.
• Targeting this module offers a new therapeutic strategy for cardiac fibrosis.